Allentown LLC Announces the Acquisition of ClorDiSys

Allentown a leading provider of life science solutions has acquired ClorDiSys to further expand Allentown’s footprint in the global biomedical research and life science markets.

Charles Simmons, CEO of Allentown stated…..

“In pursuing our strategy to provide a full spectrum of high-science equipment, consumables, and services to our trusted biomedical research customers and broadening our offerings and scientific services into adjacent life science industries, we’re thrilled when we find a leading organization that can help us pursue our goals. ClorDiSys is that type of company, offering innovative and effective decontamination solutions with integrity and care, perfectly aligned with our cause to improve science and lifesaving research.”

Dane Kmetz, Vice President of M&A and Business Development, added…

“Acquiring best-in-class companies with high-performing teams and customer-centric solutions continues to be the focal point of our growth strategy. We welcome ClorDiSys to the Allentown family and look forward to expanding the reach of their mission-critical products and services.”

ClorDiSys is a family-owned and operated company that began in 2001 as a decontamination equipment provider but quickly added surface-top disinfection products, as well as on-site decontamination services to its portfolio to better address customer challenges.

Since then, ClorDiSys has provided decontamination solutions to customers worldwide and across many industries, and much like Allentown’s path over the past 55 years, their commitment to customer satisfaction and quality has allowed them to become a market leader.

Paul Lorcheim, the Director and Co-Founder of ClorDiSys added…

“Being acquired by Allentown is exactly what we needed to broaden our reach and make our services available to many more research institutions and adjacent industries. We want to lead the world and be the catalyst of driving a better and healthier process and shift away from Ethylene Oxide (EtO) for medical device sterilization and into ClorDiSys’ chlorine dioxide gas sterilization technology. ClorDiSys is quickly expanding into the medical device sterilization market, tripling the number of locations utilizing our technology in the last year alone. Unlike EtO, our process is more efficient, non-carcinogenic, non-explosive, and greatly reduces the impact on the environment.”

With the acquisition of ClorDiSys Allentown will add decontamination, disinfection, and sterilization services to its solution offerings. This new capability will help close the loop on crucial vivarium services already provided by Allentown, allowing for the decontamination and recommissioning of essential research equipment back into service. This holistic approach will offer customers peace of mind and ease of interaction with one solutions provider, consolidating customer procurement processes and increasing the number of innovative solutions Allentown offers.

This acquisition is also in line with Allentown’s commitment to innovation and an expansion of scientific service offerings for the vivarium and broader life science markets.


Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

In addition, Wave Neuroscience has acquired the Neuro-EEG Synchronization Therapy (NEST®) system developed and tested by NeoSync.
Boston Scientific expects to complete the transaction in the first half of 2024, subject to customary closing conditions.
E Tech Group announces the immediate renaming of E-Volve Systems to E Tech Group, following their strategic acquisition on February 23, 2023, emphasizing a unified vision, expanded services, and enhanced client and market value through this integration.
Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.
SERF SAS is recognized by healthcare professionals worldwide for its innovations in hip implants, including the invention of the original Dual Mobility Cup.

By using this website you agree to accept Medical Device News Magazine Privacy Policy